HbA1c
Vitamin D supplementation → HbA1c
Vitamin D supplementation → HbA1c
Evidence profile
Key finding
Serum 25-hydroxyvitamin D rose from 25 ng/mL to 65 ng/dL within 3 months.
This case report examined the effects of high-dose vitamin D therapy on partial clinical remission in a participant with Type 1 Diabetes.
Evidence strength
Moderate confidence
Study type
Non-randomized CT
Follow-up
Long-Term (1–5 y)
Quick read
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T1 Diabetes
Intervention
High-dose vitamin D therapy
Study type
Non-randomized CT
Follow-up
Long-Term (1–5 y)
Primary outcome
Serum 25-hydroxyvitamin D
Evidence
Moderate confidence
Plain-language summary
A plain-language read of the study's main message and where it applies.
Study focus
This case report examined the effects of high-dose vitamin D therapy on partial clinical remission in a participant with Type 1 Diabetes.
These findings highlight the potential role of vitamin D in diabetes management, particularly in Type 1 Diabetes. Improved glycemic control can lead to better health outcomes and reduced complications for patients. Understanding the impact of vitamin D could inform treatment strategies and enhance patient care.
Single participant limits generalizability. Non-randomized design may introduce bias. Lack of control group reduces comparative analysis.
Published in
Publication details and source links for this paper.
Adriana CG, Kristina C, Benjamin UN. High-Dose Vitamin D Therapy Prolongs Partial Clinical Remission in Type 1 Diabetes: A Case Report. Frontiers in Endocrinology. 2026;17:1788049. doi:10.3389/fendo.2026.1788049
Save this study and add notes to your research library.
Serum 25-hydroxyvitamin D increased from 25 ng/mL to 65 ng/dL.
Hemoglobin A1c decreased from 13.8% to persistently <7%.
Insulin-dose adjusted A1c decreased from 17 to <9.
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Vitamin D supplementation and HbA1c, Insulin-dose adjusted A1c (IDAA1c), Serum 25-hydroxyvitamin D, and 2 more.
This study contributes evidence to
Primary intervention
Vitamin D supplementation
Primary outcomes
Primary intervention
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
3
Related topics
5
Evidence pairs
464
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Core evidence
The primary outcomes reported in this study.
Vitamin D supplementation → HbA1c
Vitamin D supplementation → HbA1c
Evidence profile
Vitamin D supplementation → Insulin-dose adjusted A1c (IDAA1c)
Vitamin D supplementation → Insulin-dose adjusted A1c (IDAA1c)
Evidence profile
Vitamin D supplementation → Serum 25-hydroxyvitamin D
Vitamin D supplementation → Serum 25-hydroxyvitamin D
Evidence profile
Vitamin D supplementation → Time in range
Vitamin D supplementation → Time in range
Evidence profile
Vitamin D supplementation → Total daily insulin dose
Vitamin D supplementation → Total daily insulin dose
Evidence profile
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Vitamin D supplementation and HbA1c, Vitamin D supplementation and Adipokine and Angiogenic Markers.
This study contributes to the evidence on the following intervention-outcome relationships.
Curated evidence collections and hubs this study is part of.
All studies measuring Adipokine and Angiogenic Markers
Measures Adipokine and Angiogenic Markers as a key outcome.
All studies measuring HbA1c
Measures HbA1c as a key outcome.
All studies on Vitamin D supplementation
Contributes to Vitamin D supplementation evidence base.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in the evidence archive.
5 results
5 results
5 results
5 results
5 results
Generated from the study's connected evidence using Evidence Intelligence™.
Vitamin D supplementation may improve HbA1c.
ConsensusScore™: Results are generally consistent across studies.
Ranked evidence signals
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 81.9 | moderate positive | ConsensusScore™ Generally Consistent | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Vitamin D supplementation appears to improve Serum 25-hydroxyvitamin D.
ConsensusScore™: Results are consistent across studies.
Ranked evidence signals
Serum 25-hydroxyvitamin D
EvidenceScore™ Strong | EvidenceScore™ 79.9 | strong positive | ConsensusScore™ Consistent | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Vitamin D supplementation appears to improve Insulin-dose adjusted A1c (IDAA1c).
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Insulin-dose adjusted A1c (IDAA1c)
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Vitamin D supplementation for Time in range.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Time in range
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, archive views, and research summaries.
Follow the topics this study contributes to.
Open broader archive views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.